Suspected information disclosure violations! Nengte Technology under investigation by the CSRC

【Briefing】Nante Technology was put on file for investigation by the China Securities Regulatory Commission due to suspected violations of information disclosure rules and regulations

On April 1, Nante Technology issued an announcement stating that the company received a “Filing Notice” from the China Securities Regulatory Commission. Due to suspected violations of information disclosure laws and regulations, according to laws and regulations, the China Securities Regulatory Commission has decided to file the company for investigation.

At present, all of the company’s production and operating activities are being carried out normally and in an orderly manner. During the filing investigation period, the company will actively cooperate with the China Securities Regulatory Commission’s investigation work and strictly fulfill its information disclosure obligations in a timely manner in accordance with relevant laws and regulations and regulatory requirements.

Nante Technology was listed on the Shenzhen Stock Exchange on December 29, 2006. It is a high-tech enterprise centered on the R&D, production, and sales of pharmaceutical intermediates and vitamin E.

Of note, this is not the first time the company has been pulled into an information disclosure violation controversy. The reporter reviewed past announcements and found that on December 31, 2020, due to suspected violations of information disclosure laws and regulations, the company and relevant responsible parties received an “Administrative Penalty Decision” from the Fujian Regulatory Bureau of the China Securities Regulatory Commission.

According to the findings, in the company’s 2017 semi-annual report, 2017 third-quarter report, 2017 annual report, 2018 first-quarter report, and 2018 semi-annual report, there were false records in liabilities and asset disclosures; the 2018 semi-annual report failed to disclose external guarantees, involving a major omission; and it did not disclose in interim announcements any material changes related to external guarantee matters. In response, the China Securities Regulatory Commission imposed relevant administrative penalties on the company and relevant responsible parties.

The above matters subsequently prompted some investors to file lawsuits against the company on the basis of “disputes over liability arising from false securities disclosures.” It is understood that as of August 20, 2025, the number of investors involved in Nante Technology’s investor lawsuits was a total of 1,075, with a total compensation amount of RMB 91.6652 million. Of that, the amount that has been fulfilled after court acceptance through settlement, reconciliation, and creditor withdrawal of claims was RMB 91.6585 million, and the amount being advanced through reconciliation was RMB 0.67 million.

While historical legacy issues have not yet completely faded away, in recent years the company has also continued to push forward business restructuring.

After Hubei Jingzhou Chengfa Group took control in 2022, Nante Technology began promoting reforms of “getting slimmer and stronger, and focusing on core business.” In April 2024, the company officially changed its name to “Nante Technology,” which is also viewed as an important marker of further deepening its strategic transformation.

After the name change, Nante Technology continued to advance adjustments to its business structure. To concentrate resources on developing its specialty chemical core business, it is also accelerating the disposal of non-core assets.

On July 29, 2025, Nante Technology previously issued an announcement stating that the company transferred 100% of the equity interest in its wholly owned subsidiary, Shaanxi Ankang Shungqian Mining Co., Ltd., through a public listing at the Wuhan Optics Valley Joint Equity Exchange, and the equity transfer and industrial and commercial change registration have been completed.

Judging from performance, Nante Technology’s operating side has already seen some repair. The company disclosed that it expects its 2025 attributable net profit to be RMB 200 million to RMB 250 million, turning from loss to profit year over year.

The company stated that the vitamin E business of its wholly owned subsidiary has been operating well, generating profits of no less than RMB 660 million for the company, thereby driving a substantial growth in the company’s 2025 performance compared with the same period of the previous year.

As of the close on April 1, Nante Technology’s shares were trading at RMB 3.33 per share, with a latest market capitalization of RMB 8.244 billion.

（Source: China Fund News）